JP Stock MarketDetailed Quotes

7775 Daiken Medical

Watchlist
  • 518
  • +2+0.39%
20min DelayMarket Closed Jan 10 15:30 JST
16.49BMarket Cap15.05P/E (Static)

Daiken Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
Total revenue
6.71%9.75B
4.60%2.34B
5.74%2.58B
9.05%2.46B
7.53%2.36B
6.99%9.14B
5.70%2.24B
4.59%2.44B
7.08%2.26B
11.09%2.2B
Cost of revenue
2.88%5.77B
-7.21%1.44B
3.80%1.5B
7.25%1.43B
9.50%1.4B
15.45%5.61B
21.44%1.55B
10.07%1.44B
14.79%1.33B
15.60%1.28B
Gross profit
12.80%3.98B
31.17%904.43M
8.54%1.08B
11.64%1.04B
4.78%958.01M
-4.17%3.53B
-18.17%689.5M
-2.42%998.96M
-2.33%927.37M
5.33%914.33M
Operating expense
2.57%2.54B
15.61%699.22M
-6.64%592.14M
3.08%629.15M
-1.19%618.84M
-2.27%2.48B
-3.29%604.8M
-3.23%634.22M
-3.61%610.36M
1.17%626.32M
Operating profit
36.81%1.44B
142.25%205.21M
34.93%492.12M
28.12%406.15M
17.76%339.17M
-8.38%1.05B
-61.00%84.71M
-0.98%364.73M
0.22%317.01M
15.66%288.01M
Net non-operating interest income (expenses)
-21.69%-4.83M
-15.60%-1.21M
-27.50%-1.21M
-21.05%-1.2M
-23.21%-1.21M
-6.10%-3.97M
-20.67%-1.05M
-4.40%-949K
0.90%-993K
-1.88%-978K
Non-operating interest income
--0
--0
--0
----
----
--0
--0
--0
----
----
Non-operating interest expense
21.69%4.83M
15.60%1.21M
27.50%1.21M
21.05%1.2M
23.21%1.21M
6.10%3.97M
20.67%1.05M
4.40%949K
-0.90%993K
1.88%978K
Net investment income
526.72%2.91M
3,000.00%868K
29.45%-194K
-6.06%93K
249.84%2.14M
-60.14%464K
-97.15%28K
-759.38%-275K
201.02%99K
96.78%612K
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
60.90%-11.19M
71.16%-8.26M
-6,936.49%-5.06M
4,414.00%2.16M
-26K
-2,658.82%-28.61M
-20,953.68%-28.63M
135.24%74K
87.28%-50K
0
Less:Other special charges
-60.90%11.19M
-71.16%8.26M
6,936.49%5.06M
---2.16M
--26K
2,658.82%28.61M
20,953.68%28.63M
-135.24%-74K
----
----
Other non-operating income (expenses)
158.71%6.92M
79.89%2M
589.49%2.03M
37.74%1.08M
275.73%1.8M
-34.27%2.67M
-20.14%1.11M
-67.29%295K
29.65%787K
-58.93%478K
Income before tax
40.14%1.44B
253.60%198.62M
34.03%487.69M
28.86%408.28M
18.66%341.88M
-10.97%1.03B
-74.30%56.17M
-1.14%363.88M
0.45%316.85M
15.60%288.13M
Income tax
43.10%447.86M
204.56%98.17M
30.63%137.21M
28.34%115.37M
13.18%97.11M
-2.28%312.96M
-35.09%32.23M
-1.11%105.04M
-1.72%89.89M
17.63%85.8M
Net income
38.84%988.6M
319.65%100.45M
35.40%350.48M
29.06%292.91M
20.98%244.77M
-14.32%712.06M
-85.83%23.94M
-1.16%258.84M
1.34%226.96M
14.76%202.33M
Net income continuous operations
38.84%988.6M
319.63%100.45M
35.40%350.48M
29.06%292.91M
20.98%244.77M
-14.32%712.06M
-85.83%23.94M
-1.16%258.84M
1.34%226.96M
14.76%202.33M
Noncontrolling interests
Net income attributable to the company
38.84%988.6M
319.65%100.45M
35.40%350.48M
29.06%292.91M
20.98%244.77M
-14.32%712.06M
-85.83%23.94M
-1.16%258.84M
1.34%226.96M
14.76%202.33M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
38.84%988.6M
319.65%100.45M
35.40%350.48M
29.06%292.91M
20.98%244.77M
-14.32%712.06M
-85.83%23.94M
-1.16%258.84M
1.34%226.96M
14.76%202.33M
Gross dividend payment
Basic earnings per share
38.81%34.41
315.48%3.49
35.41%12.2
29.11%10.2
21.02%8.52
-14.31%24.79
-85.71%0.84
-1.21%9.01
1.41%7.9
14.66%7.04
Diluted earnings per share
38.81%34.41
318.88%3.49
35.40%12.1997
29.06%10.1958
21.02%8.52
-14.31%24.79
-85.83%0.8332
-1.16%9.01
1.41%7.9
14.66%7.04
Dividend per share
5.00%21
9.09%12
0
0.00%9
0
0.00%20
0.00%11
0
0.00%9
0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Mar 31, 2024 (Q4)Mar 31, 2024 (Q3)Dec 31, 2023 (Q2)Sep 30, 2023 (Q1)Jun 30, 2023 (FY)Mar 31, 2023 (Q4)Mar 31, 2023 (Q3)Dec 31, 2022 (Q2)Sep 30, 2022 (Q1)Jun 30, 2022
Total revenue 6.71%9.75B 4.60%2.34B 5.74%2.58B 9.05%2.46B 7.53%2.36B 6.99%9.14B 5.70%2.24B 4.59%2.44B 7.08%2.26B 11.09%2.2B
Cost of revenue 2.88%5.77B -7.21%1.44B 3.80%1.5B 7.25%1.43B 9.50%1.4B 15.45%5.61B 21.44%1.55B 10.07%1.44B 14.79%1.33B 15.60%1.28B
Gross profit 12.80%3.98B 31.17%904.43M 8.54%1.08B 11.64%1.04B 4.78%958.01M -4.17%3.53B -18.17%689.5M -2.42%998.96M -2.33%927.37M 5.33%914.33M
Operating expense 2.57%2.54B 15.61%699.22M -6.64%592.14M 3.08%629.15M -1.19%618.84M -2.27%2.48B -3.29%604.8M -3.23%634.22M -3.61%610.36M 1.17%626.32M
Operating profit 36.81%1.44B 142.25%205.21M 34.93%492.12M 28.12%406.15M 17.76%339.17M -8.38%1.05B -61.00%84.71M -0.98%364.73M 0.22%317.01M 15.66%288.01M
Net non-operating interest income (expenses) -21.69%-4.83M -15.60%-1.21M -27.50%-1.21M -21.05%-1.2M -23.21%-1.21M -6.10%-3.97M -20.67%-1.05M -4.40%-949K 0.90%-993K -1.88%-978K
Non-operating interest income --0 --0 --0 ---- ---- --0 --0 --0 ---- ----
Non-operating interest expense 21.69%4.83M 15.60%1.21M 27.50%1.21M 21.05%1.2M 23.21%1.21M 6.10%3.97M 20.67%1.05M 4.40%949K -0.90%993K 1.88%978K
Net investment income 526.72%2.91M 3,000.00%868K 29.45%-194K -6.06%93K 249.84%2.14M -60.14%464K -97.15%28K -759.38%-275K 201.02%99K 96.78%612K
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges) 60.90%-11.19M 71.16%-8.26M -6,936.49%-5.06M 4,414.00%2.16M -26K -2,658.82%-28.61M -20,953.68%-28.63M 135.24%74K 87.28%-50K 0
Less:Other special charges -60.90%11.19M -71.16%8.26M 6,936.49%5.06M ---2.16M --26K 2,658.82%28.61M 20,953.68%28.63M -135.24%-74K ---- ----
Other non-operating income (expenses) 158.71%6.92M 79.89%2M 589.49%2.03M 37.74%1.08M 275.73%1.8M -34.27%2.67M -20.14%1.11M -67.29%295K 29.65%787K -58.93%478K
Income before tax 40.14%1.44B 253.60%198.62M 34.03%487.69M 28.86%408.28M 18.66%341.88M -10.97%1.03B -74.30%56.17M -1.14%363.88M 0.45%316.85M 15.60%288.13M
Income tax 43.10%447.86M 204.56%98.17M 30.63%137.21M 28.34%115.37M 13.18%97.11M -2.28%312.96M -35.09%32.23M -1.11%105.04M -1.72%89.89M 17.63%85.8M
Net income 38.84%988.6M 319.65%100.45M 35.40%350.48M 29.06%292.91M 20.98%244.77M -14.32%712.06M -85.83%23.94M -1.16%258.84M 1.34%226.96M 14.76%202.33M
Net income continuous operations 38.84%988.6M 319.63%100.45M 35.40%350.48M 29.06%292.91M 20.98%244.77M -14.32%712.06M -85.83%23.94M -1.16%258.84M 1.34%226.96M 14.76%202.33M
Noncontrolling interests
Net income attributable to the company 38.84%988.6M 319.65%100.45M 35.40%350.48M 29.06%292.91M 20.98%244.77M -14.32%712.06M -85.83%23.94M -1.16%258.84M 1.34%226.96M 14.76%202.33M
Preferred stock dividends
Other under preferred stock dividend 0 0 0 0 0 0 0 0 0 0
Net income attributable to common stockholders 38.84%988.6M 319.65%100.45M 35.40%350.48M 29.06%292.91M 20.98%244.77M -14.32%712.06M -85.83%23.94M -1.16%258.84M 1.34%226.96M 14.76%202.33M
Gross dividend payment
Basic earnings per share 38.81%34.41 315.48%3.49 35.41%12.2 29.11%10.2 21.02%8.52 -14.31%24.79 -85.71%0.84 -1.21%9.01 1.41%7.9 14.66%7.04
Diluted earnings per share 38.81%34.41 318.88%3.49 35.40%12.1997 29.06%10.1958 21.02%8.52 -14.31%24.79 -85.83%0.8332 -1.16%9.01 1.41%7.9 14.66%7.04
Dividend per share 5.00%21 9.09%12 0 0.00%9 0 0.00%20 0.00%11 0 0.00%9 0
Currency Unit JPY JPY JPY JPY JPY JPY JPY JPY JPY JPY
Accounting Standards NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP NonUS-GAAP
Top JP Stock Gainers
Symbol Price % Chg
Axel Mark
3624
201 +21.08%
Renascience
4889
462 +20.94%
Ecomott
3987
465 +20.78%
Festaria Holdings
2736
1770 +20.41%
Tecnisco
2962
473 +20.36%

See the daily top gainer.